NRK | Nik related kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
NTF3 | Neurotrophin 3 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
OXTR | Oxytocin receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PABPC5 | Poly(A) binding protein, cytoplasmic 5 | | | | | | Tissue enhanced |
PCDH11X | Protocadherin 11 X-linked | Predicted membrane proteins
| | | | | Tissue enhanced |
PDGFD | Platelet derived growth factor D | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PEG3 | Paternally expressed 3 | Transcription factors
| | | | | Tissue enhanced |
PLA2G5 | Phospholipase A2, group V | Disease related genes Enzymes Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLCXD3 | Phosphatidylinositol-specific phospholipase C, X domain containing 3 | | | | | | Tissue enhanced |
PRSS35 | Protease, serine, 35 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
RASL11B | RAS-like, family 11, member B | | | | | | Tissue enhanced |
RBP1 | Retinol binding protein 1, cellular | | | | | | Tissue enhanced |
RP11-366L20.2 | Uncharacterized protein | | | | | | Tissue enhanced |
RP6-24A23.6 | Uncharacterized protein | | | | | | Tissue enhanced |
SCN7A | Sodium channel, voltage-gated, type VII, alpha subunit | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SCUBE1 | Signal peptide, CUB domain, EGF-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
SERHL2 | Serine hydrolase-like 2 | Plasma proteins
| | | | | Tissue enhanced |
SGCZ | Sarcoglycan, zeta | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SNCAIP | Synuclein, alpha interacting protein | Disease related genes
| | | | | Tissue enhanced |
STXBP5L | Syntaxin binding protein 5-like | | | | | | Tissue enhanced |
TCF23 | Transcription factor 23 | Transcription factors
| | | | | Tissue enhanced |
TENM4 | Teneurin transmembrane protein 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM221 | Transmembrane protein 221 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM255A | Transmembrane protein 255A | Predicted membrane proteins
| | | | | Tissue enhanced |
TRO | Trophinin | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
TYRO3 | TYRO3 protein tyrosine kinase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
VIT | Vitrin | Predicted secreted proteins
| | | | | Tissue enhanced |
VLDLR | Very low density lipoprotein receptor | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
VSX1 | Visual system homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
VWC2 | Von Willebrand factor C domain containing 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
VWCE | Von Willebrand factor C and EGF domains | Predicted secreted proteins
| | | | | Tissue enhanced |
WIPF3 | WAS/WASL interacting protein family, member 3 | | | | | | Tissue enhanced |
WISP2 | WNT1 inducible signaling pathway protein 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ZFPM2 | Zinc finger protein, FOG family member 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ZNF556 | Zinc finger protein 556 | Transcription factors
| | | | | Tissue enhanced |
ZNF66 | Zinc finger protein 66 | Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
ZNF98 | Zinc finger protein 98 | Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |